Reza Maleki
Higher Degree by Research Candidate
Adelaide Medical School
Faculty of Health and Medical Sciences
-
Journals
Year Citation 2025 Ghith, A., Maleki, R., Grzeskowiak, L. E., Amir, L. H., & Ingman, W. V. (2025). Challenges and Opportunities in Quantifying Bioactive Compounds in Human Breastmilk. Biomolecules, 15(3), 325-1-325-20.
2024 Noori, E., Hashemi, N., Rezaee, D., Maleki, R., Shams, F., Kazemi, B., . . . Rahimi, F. (2024). Potential therapeutic options for celiac Disease: An update on Current evidence from Gluten-Free diet to cell therapy. International Immunopharmacology, 133, 112020.
Scopus22024 Sadraeian, M., Maleki, R., Moraghebi, M., & Bahrami, A. (2024). Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases. Molecules, 29(13), 3002.
Scopus5 Europe PMC22024 Maleki, R., Ghith, A., Heydarlou, H., Grzeskowiak, L. E., & Ingman, W. V. (2024). The Role of Breastmilk in Macrophage-Tumour Cell Interactions in Postpartum Breast Cancer. Frontiers in Bioscience-Landmark, 29(9), 328-1-328-12.
Scopus1 Europe PMC12023 Maleki, R., Rahimpour, A., & Rajabibazl, M. (2023). Construction and evaluation of wild and mutant ofatumumab scFvs against the human CD20 antigen. Preparative Biochemistry and Biotechnology, 53(3), 239-246.
Scopus1 WoS12022 Ghasemian, M., Rajabibazl, M., Sahebi, U., Sadeghi, S., Maleki, R., Hashemnia, V., & Mirfakhraie, R. (2022). Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders. Cancer Cell International, 22(1), 12 pages.
Scopus19 WoS7 Europe PMC172021 Moraghebi, M., Maleki, R., Ahmadi, M., Negahi, A. A., Abbasi, H., & Mousavi, P. (2021). In silico Analysis of Polymorphisms in microRNAs Deregulated in Alzheimer Disease. Frontiers in Neuroscience, 15, 17 pages.
Scopus6 WoS4 Europe PMC7- Maleki, R., Fu, L., Diaz, R. S., Guimarães, F. E. G., Cabral-Marques, O., Cabral-Miranda, G., & Sadraeian, M. (n.d.). Reducing the Immunogenicity of Pulchellin A-Chain, Ribosome-Inactivating Protein Type 2, by Computational Protein Engineering for Potential New Immunotoxins. J, 6(1), 85-101.
Connect With Me
External Profiles
